DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME

Authors

  • Lismeia Raimundo SOARES Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro
  • Daniela Cardeal da SILVA São Paulo University Medical School; Secondary Immunodeficiencies Outpatient Clinic; Dermatology Department; Universidade de São Paulo
  • Claudio R. GONSALEZ São Paulo University Medical School; Secondary Immunodeficiencies Outpatient Clinic; Dermatology Department; Universidade de São Paulo
  • Felipe G. BATISTA São Paulo University Medical School; Secondary Immunodeficiencies Outpatient Clinic; Dermatology Department; Universidade de São Paulo
  • Luiz Augusto M. FONSECA São Paulo University Medical School; Preventive Medicine Department; Universidade de São Paulo
  • Alberto J.S. DUARTE São Paulo University Medical School; Secondary Immunodeficiencies Outpatient Clinic; Dermatology Department; Universidade de São Paulo
  • Jorge CASSEB São Paulo University Medical School; Secondary Immunodeficiencies Outpatient Clinic; Dermatology Department; Universidade de São Paulo

Abstract

Introduction: Highly Active Antiretroviral Therapy (HAART) has improved and extended the lives of thousands of people living with HIV/AIDS around the world. However, this treatment can lead to the development of adverse reactions such as lipoatrophy/lipohypertrophy syndrome (LLS) and its associated risks. Objective: This study was designed to assess the prevalence of self-reported lipodystrophy and nutritional status by anthropometric measurements in patients with HIV/AIDS. Methods: An observational study of 227 adult patients in the Secondary Immunodeficiencies Outpatient Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (3002 ADEE-HCFMUSP). The sample was divided into three groups; Group 1 = 92 patients on HAART and with self-reported lipodystrophy, Group 2 = 70 patients on HAART without self-reported lipodystrophy and Group 3 = 65 patients not taking HAART. The nutritional status of individuals in the study sample was determined by body mass index (BMI) and percentage of body fat (% BF). The cardiovascular risk and diseases associated with abdominal obesity were determined by waist/hip ratio (WHR) and waist circumference (WC). Results: The prevalence of self-reported lipoatrophy/lipohypertrophy syndrome was 33% among women and 59% among men. Anthropometry showed depletion of fat mass in the evaluation of the triceps (TSF) in the treatment groups with HAART and was statistically independent of gender; for men p = 0.001, and for women p = 0.007. Similar results were found in the measurement of skin folds of the upper and lower body (p = 0.001 and p = 0.003 respectively). In assessing the nutritional status of groups by BMI and % BF, excess weight and body fat were more prevalent among women compared to men (p = 0.726). The WHR and WC revealed risks for cardiovascular and other diseases associated with abdominal obesity for women on HAART and with self-reported LLS (p = 0.005) and (p = 0.011). Conclusions: Anthropometric measurements were useful in the confirmation of the prevalence of LLS. BMI alone does not appear to be a good parameter for assessing the nutritional status of HIV-infected patients on HAART and with LLS. Other anthropometric measurements are needed to evaluate patients with the lipoatrophy/lipohypertrophy syndrome.

Downloads

Download data is not yet available.

Downloads

Published

2015-04-01

How to Cite

SOARES, L. R., SILVA, D. C. da, GONSALEZ, C. R., BATISTA, F. G., FONSECA, L. A. M., DUARTE, A. J., & CASSEB, J. (2015). DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME . Revista Do Instituto De Medicina Tropical De São Paulo, 57(2), 105-110. Retrieved from http://www.revistas.usp.br/rimtsp/article/view/100926

Issue

Section

HIV